Keyphrases
Chemotherapy
100%
Colorectal Cancer Patients
100%
KRAS mutation
100%
BRAF mutation
100%
Microsatellite Status
100%
Microsatellite Stable
50%
Oxaliplatin
37%
Patients with Colorectal Cancer
37%
5-fluorouracil (5-FU)
37%
Mutated KRAS
37%
Mutant Protein
25%
Two-level
25%
Colorectal Cancer
25%
Therapeutic Strategies
12%
Cancer Therapy
12%
SW480
12%
Repair Method
12%
Colorectal Tissue
12%
Overall Survival Rate
12%
HCT116 Cells
12%
Immunoblot
12%
Young Patients
12%
Elderly Patients
12%
HCT116
12%
Colorectal Cancer Cell Lines
12%
Oncogenic Potential
12%
SW480 Cells
12%
Genetic Polymorphism
12%
Mismatch Repair
12%
Codon 13
12%
Disease-specific Survival
12%
Adjuvant Chemotherapy
12%
Microsatellite Instability-high (MSI-H)
12%
KRAS Codon 12
12%
Stability Indicating
12%
Microsatellite Instable
12%
BRAF V600E
12%
Immunology and Microbiology
Survival Rate
100%
Codon
50%
Western Blot
50%
Cancer Tissue
50%
Overall Survival
50%
Colorectal Cancer Cell Line
50%
Mismatch Repair
50%
Genetic Polymorphism
50%
Disease Specific Survival
50%
Microsatellite Instability
50%
Biochemistry, Genetics and Molecular Biology
KRAS
100%
Microsatellite
100%
Fluorouracil
18%
Survival Rate
12%
Cancer Cell
6%
Overall Survival
6%
Codon
6%
Prospective Study
6%
Genetic Polymorphism
6%
DNA Mismatch Repair
6%
Microsatellite Instability
6%
Disease Specific Survival
6%
Immunoblotting
6%
Neuroscience
Microsatellite
100%
Oxaliplatin
27%
Fluorouracil
27%
Cell Line
9%
Codon
9%
DNA Mismatch Repair
9%
Genetic Polymorphism
9%
Microsatellite Instability
9%
Immunoblotting
9%